Metraipolis › archive › dc_fbcd8e9d3ebe

Evaluating the health economic impact of cefepime/enmetazobactam in complicated urinary tract infections in the German setting: a cost analysis from payer… — Europe PMC PMID:41454156

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41454156
DOI
10.1007/s15010-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-11-07T10:01:49.357Z
SHA-256 of the archived text
2598cac75a9ece80388821f6ee43aab67008958ac75b955ed1d7e0a688b9e0a7
Stable URL of this page
https://metraipolis.com/documento/dc_fbcd8e9d3ebe

How to cite

Evaluating the health economic impact of cefepime/enmetazobactam in complicated urinary tract infections in the German setting: a cost analysis from payer… — Europe PMC PMID:41454156 — Europe PMC (en), https://europepmc.org/article/MED/41454156 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fbcd8e9d3ebe (Metraipolis archive dc_fbcd8e9d3ebe, sha256 2598cac75a9ece80388821f6ee43aab67008958ac75b955ed1d7e0a688b9e0a7)
BibTeX
@misc{dcfbcd8e9d3ebe,
  title = {Evaluating the health economic impact of cefepime/enmetazobactam in complicated urinary tract infections in the German setting: a cost analysis from payer… — Europe PMC PMID:41454156},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41454156},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fbcd8e9d3ebe; sha256 2598cac75a9ece80388821f6ee43aab67008958ac75b955ed1d7e0a688b9e0a7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41454156. Agents can read the archived copy with the MCP tool read_document.